Urokinase-plasminogen-activator levels and prognosis in 69 soft-tissue sarcomas

International Journal of Cancer

Volumn 69, Issue 4, 1996, Pages 268-272

  Choong, Peter F M ^a,b   Fernö, Mårten ^a   Åkermans, Mans ^a   Willëm, Helena ^a   Lånoström, Eva ^a   Gustafson, Pelle ^a   Alvegård, Thor ^a   Rydholm, Anders ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOASSAY; LEIOMYOSARCOMA; LIPOSARCOMA; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SARCOMA; SARCOMA, SYNOVIAL; URINARY PLASMINOGEN ACTIVATOR;

EID: 0029800492     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960822)69:4<268::AID-IJC5>3.0.CO;2-V     Document Type: Article

References (35)

1. ALVEGÅRD, T.A., BERG, N.O., BALDETORP, B., FERNÖ, M., KILLANDER, D., RANSTAM, J, RYDHOLM, A. and ÅKERMAN, M., Cellular DNA content and prognosis of high-grade soft-tissue sarcoma: the Scandinavian Sarcoma Group experience. J. clin. Oncol., 8, 538-547 (1990).
2. ALVEGÅRD, T.A., SIGURDSSON, H., MOURIDSEN, H., SOLHEIM, Ø., UNSGAARD, B., RINGBORG, U., DAHL, O., NORDENTOFT, A.M., BLOMOVIST, C., RYDHOLM, A., STENER, B. and RANSTAM, J., Adjuvant chemotherapy with doxorubicin in high-grade soft-tissue sarcoma: a randomised trial of the Scandinavian Sarcoma Group. J. clin. Oncol., 7, 1504-1513 (1989).
3. ANGERVALL, L., KINDBLOM, L.-G., RYDHOI.M, A. and STENER, B., The diagnosis and prognosis of soft-tissue tumours. Semin. diagnostic Pathol., 3, 240-258 (1986).
4. CARLSEN, S.A., RAMSHAW, I.A. and WARRINGTON, R.C., Involvement of plasminogen-activator production with tumor metastasis in a rat model. J. Cancer Res., 44, 3012-3016 (1984).
5. CHANG, H.R., GAYNOR, J., TAN, C., HAJDU, S.I. and BRENNAN, M.F., Multifactorial analysis of survival in primary extremity liposarcoma. World J. Surg., 14, 610-618 (1990).
6. CHOONG, P.F.M., GUSTAFSON, P., WILLÉN, H., ÅKERMAN, M., BALDETORP, B., FERNÖ, M., ALVEGÅRD, T. and RYDHOLM, A., Prognosis following locally recurrent soft-tissue sarcoma. A staging system based on primary and recurrent tumor characteristics. Int. J. Cancer, 60, 33-37 (1995).
7. DANØ, K., ANDREASEN, P.A., GRØNDAHL-HANSEN, J., KRISTENSEN, P.I., NIELSEN, L.S. and SKRIVER, L., Plasminogen activators, tissue degradation and cancer. Advanc. Cancer Res., 44, 139-266 (1985).
8. DUFFY, M.J., The role of proteolytic enzymes in cancer invasion and metastasis. Clin. exp. Metast., 10, 145-155 (1992).
9. DUFFY, M.J., REILLY, D., MCDERMOTT, E., O'HIGGINS, K. FENNELLY, J.J. and ANDREASEN, P.A., Urokinase-plasminogen activator as a prognostic marker in different sub-groups of patients with breast cancer. Cancer, 74, 2276-2280 (1994).
10. EISENBACH, L., SEGAL, S. and FELDMAN, M., Proteolytic enzymes in tumor metastasis. 1. Plasminogen activator in clones of Lewis lung carcinoma and T10 sarcoma. J. nat. Cancer Inst., 74, 77-85 (1985).
11. ELLIS, V., PYKE, C., ERIKSON, J., SOLBERG, H. and DANØ, K., The urokinase receptor: involvement in cell-surface proteolysis and cancer invasion. Ann. N. Y. Acad. Sci., 667, 13-31 (1992).
12. ENNEKING, W.F., A system of staging musculoskeletal neoplasms. Clin. Orthop., 204, 9-24 (1986).
13. ENZINGER, P.M. and WEISS, S.W., General considerations. In: P.M. Enzinger and S.W. Weiss (eds.), Soft-tissue tumors, pp. 1-16, Mosby, St. Louis (1995a).
14. ENZINGER, P.M. and WEISS, S.W., Malignant fibrohistiocytic tumors. In: P.M. Enzinger and S.W. Weiss (eds.). Soft-tissue tumors, pp. 351-380, Mosby, St. Louis (1995b).
15. FERNö, M., BALDETORP, B. and AKERMAN, M., Flow-cytometric DNA ploidy analysis of soft-tissue sarcomas. A comparative study of preoperative fine-needle aspirates and post-operative fresh tissues and archival material. Anal. Quant. Cytol. Histol., 12, 251-258 (1990).
16. FERNö, M., BENDAHL, P.-O., BORG, A., BRUNDELL, J., LOTTA, H., OLSSON, H. and KILLANDER, D., Urokinase-plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid-receptor cytosols with a luminometric immunoassay. European Journal of Cancer (Eur of Cancer) in press (1996) (1995).
17. FOEKENS, J.A., BUESSECKER, F., PETERS, H.A., KRAINICK, U., VAN, P.W., LOOK, M.P., KLIJN, J.G. and KRAMER, M.D., Plasminogen-activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer. Cancer Res., 55, 1423-1427 (1995).
18. GUSTAFSON, P., Soft-tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta orthop. scand., 65, 1-31 (1994).
19. HASUI, Y., MARUTSUKA, K., NISHI, S., KITADA, S., OSADA, Y. and SUMIYOSHI, A., The content of urokinase-type plasminogen activator and tumor recurrence in superficial bladder cancer. J. Urol., 151, 16-19 (1994).
20. JÄNICKE, F., FACHE, L., SCHMITT, M., ULM, K., THOMSSEN, C., PRECHTE, A. and GRAEFE, H., Both the cytosols and detergent extracts of breast-cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen-activator inhibitor type 1. Cancer Res., 54, 2527-2530 (1994).
21. KOBAYASHI, H., FUJISHIRO, S., and TERAO, T., Impact of urokinasetype plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus. Cancer Res., 54, 6539-6548 (1994).
22. LOWRY, O.H., ROSEBOROUOH, N., FARR, L. and RANDALI., R.J., Protein measurement with the Folin phenol reagent. J. biol. Chem., 193, 265-275 (1951).
23. NEKARDA, H., SCHMITT, M., ULM, K., WENNINGER, A., VOGELSANG, H., BECKER, K., RODER, J.D., FINK, U. and SIEWERT, J.R., Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res., 54, 2900-2907 (1994).
24. OKA, T., ISHIDA, T., NISHINO, T. and SUGIMACHI, K., Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic tumors of pulmonary adenocarcinoma. Cancer Res., 51, 3522-3525 (1991).
25. PETERSEN, L.C., LUND. L.R., NIELSEN, L.S., DANO, K. and SKRIVER. L., One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. J. biol. Chem., 263, 11189-11195 (1988).
26. PISTERS, P.W., HARRISON, L.B., WOODRUFF, J.M., GAYNOR, J.J. and BRENNAN, M.F., A prospective randomized trial of adjuvant brachytherapy in the management of low-grade soft tissue sarcomas of the extremity and superficial trunk. J. clin. Oncol., 12, 1150-1155 (1994).
27. PLESNER, T., RALFKIAER, E., WITTRUP, M., JOHNSEN, H., PYKE, C., PEDERSEN, T.L., HANSEN, N.E. and DANØ. K., Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. Amer. J. clin. Pathol., 102, 835-841 (1994).
28. ROBINSON, M., BARR, L., FISHER, C., FRYATT, I., STOTTER, A., HARMER, C., WIETSHAW, E. and WESTBURY, G., Treatment of extremity soft-tissue sarcomas with surgery and radiotherapy. Radiother. Oncol., 18, 221-233 (1990).
29. RÖÖSER, B., BERG, N.O., RANSTAM, J., RYDHOLM, A. and WIEIÉN, H., Prediction of survival in patients with high-grade soft-tissue sarcoma. Int. Orthop., 14, 199-204 (1990).
30. 1-like molecule by plasmin during co-culture. J. Cell Biol., 109, 309-315 (1989).
31. SHAH, V., KUMAR, S. and ZIRVI, K.A., Metastasis of human colon tumor cells in vivo: correlation with the over-expression of plasminogen activators and 72-kDa gelatinase. In Vivo, 8, 321-326 (1994).
32. SINGER, S., CORSON, J.M., GONIN, R., LABOW, B. and EBERLHIN, T.J., Prognostic factors predictive of survival and local recurrence for extremity soft-tissue sarcoma. Ann. Surg., 219, 165-173 (1994).
33. TSUBOI, R. and RIFKIN, D.B., Bimodal relationship between invasion of the amniotic membrane and plasminogen-activator activity. Int. J. Cancer, 46, 56-60 (1990).
34. WADA, K., TAKAHASHI, H., HANANO, M., TATEWAKI, W., NIWANO, H., SEKI, Y. and SHIBATA, A., Plasma urokinase-type plasminogen activator in patients with leukemias. Leuk. Lymphoma, 15, 499-502 (1994).
35. WANG, B.S., MCLOUGHLIN, G.A., RICHIE, J.P. and MANNICK, J.A., Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. Cancer Res., 40, 288-292 (1980).